The Patent Finder

Genset S.A.

Also on record
Records under this name other than patents Genset S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Genset S.A.

PatentTitleStatus Expires Confidence
US 7,393,663Expressed Sequence Tags and Encoded Human Proteins
Formerly held
Term ended
Term ended Mar 31, 2020 · Medium confidence
Term endedTerm ended Mar 31, 2020Medium confidence
US 7,575,913Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
Formerly held
Term ended
Term ended Jan 24, 2020 · From the USPTO record
Term endedTerm ended Jan 24, 2020From the USPTO record
US 7,910,329Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
Formerly held
Term ended
Term ended Nov 30, 2018 · From the USPTO record
Term endedTerm ended Nov 30, 2018From the USPTO record
US 8,143,024Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
Formerly held
Term ended
Term ended Nov 30, 2018 · From the USPTO record
Term endedTerm ended Nov 30, 2018From the USPTO record
US 7,041,490Chlamydia trachomatis polynucleotides and vectors, recombinant host cells, DNA chips or kits containing the same
Formerly held
Lapsed on the fee record
Ended May 9, 2018 · From the USPTO record
Lapsed on the fee recordEnded May 9, 2018From the USPTO record
US 6,140,049Detection and early diagnosis of prostate cancer
Formerly held
Term ended
Term ended Apr 29, 2018 · From the USPTO record
Term endedTerm ended Apr 29, 2018From the USPTO record
US 7,015,030Microfluidic devices and uses thereof in biochemical processes
Formerly held
Lapsed on the fee record
Ended Mar 21, 2018 · From the USPTO record
Lapsed on the fee recordEnded Mar 21, 2018From the USPTO record
US 6,187,913Covalently crosslinked oligonucleotides, preparation method and synthon which is of use in the method
Formerly held
Term ended
Term ended Dec 23, 2017 · From the USPTO record
Term endedTerm ended Dec 23, 2017From the USPTO record
US 6,977,145Method for Carrying Out a Biochemical Protocol in Continuous Flow in a Microreactor
Formerly held
Lapsed on the fee record
Ended Dec 20, 2017 · Medium confidence
Lapsed on the fee recordEnded Dec 20, 2017Medium confidence
US 6,222,0295' ESTs for secreted proteins expressed in brain
Formerly held
Term ended
Term ended Aug 1, 2017 · From the USPTO record
Term endedTerm ended Aug 1, 2017From the USPTO record
10 of 121 patents shown.
Pro members see all 121.
Pro members: see all 121 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited